# FDA Inspection 816247 - Oleksandra Stasyshyn, MD, PhD - January 25, 2013

Source: https://www.keypedia.com/records/fda_inspections/oleksandra-stasyshyn-md-phd/3fdc6df3-9a49-4514-a723-12dfa0c925f7
Source feed: FDA_Inspections

> FDA Inspection 816247 for Oleksandra Stasyshyn, MD, PhD on January 25, 2013. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 816247
- Company Name: Oleksandra Stasyshyn, MD, PhD
- Inspection Date: 2013-01-25
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Bioresearch Monitoring
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 980891 - 2016-07-01](https://www.keypedia.com/records/fda_inspections/oleksandra-stasyshyn-md-phd/118e280b-0c23-42ed-a25e-1e0facdfe32f)

Company: https://www.keypedia.com/companies/oleksandra-stasyshyn-md-phd/cfdc0c3a-e27a-4576-aa5f-00fe609cf788

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d